1-3 of 3
Stephanie Van Derbur
Close
Sort by
Journal Articles

Ruxolitinib (RUX) in Combination with Azacytidine (AZA) in Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Naval G. Daver, MD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, Prithviraj Bose, MD, Lingsha Zhou, Sherry Pierce, BSN, BA, Stephanie Van Derbur, Carla Kay Tuttle, RN, Gautam Borthakur, MD, Zeev Estrov, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4246.
https://doi.org/10.1182/blood.V128.22.4246.4246
Published: 2016
Journal Articles

Ruxolitinib (RUX) in Combination with 5-Azacytidine (AZA) As Therapy for Patients (pts) with Myelofibrosis (MF)

Naval Daver, MD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, Prithviraj Bose, MD, Lingsha Zhou, Sherry Pierce, BSN, BA, Stephanie Van Derbur, Gautam Borthakur, MD, Zeev Estrov, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1127.
https://doi.org/10.1182/blood.V128.22.1127.1127
Published: 2016
Journal Articles

5-Azacytidine (AZA) in Combination with Ruxolitinib (RUX) As Therapy for Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Naval Daver, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Lingsha Zhou, Sherry Pierce, BSN, BA, Naveen Pemmaraju, MD, Elias Jabbour, Courtney DiNardo, MD, Tapan Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Marina Konopleva, MD PhD, Franklin Wynn, Stephanie Van Derbur, Zeev Estrov, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD
Journal: Blood
Blood (2015) 126 (23): 823.
https://doi.org/10.1182/blood.V126.23.823.823
Published: 2015